Works in Diabetes, Obesity & Metabolism, 2020, Vol 22, Issue 10
Results: 33
Cover Image, Volume 22, Issue 10.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1, doi. 10.1111/dom.14188
- By:
- Publication type:
- Article
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1925, doi. 10.1111/dom.14142
- By:
- Publication type:
- Article
Diabetes, obesity and COVID‐19: A complex interplay.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1892, doi. 10.1111/dom.14134
- By:
- Publication type:
- Article
Admission fasting blood glucose predicts 30‐day poor outcome in patients hospitalized for COVID‐19 pneumonia.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1955, doi. 10.1111/dom.14132
- By:
- Publication type:
- Article
Body mass index and the risk of COVID‐19 across ethnic groups: Analysis of UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1953, doi. 10.1111/dom.14125
- By:
- Publication type:
- Article
Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1915, doi. 10.1111/dom.14124
- By:
- Publication type:
- Article
The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonists
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1886, doi. 10.1111/dom.14110
- By:
- Publication type:
- Article
Lower risk of severe hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1880, doi. 10.1111/dom.14109
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1857, doi. 10.1111/dom.14108
- By:
- Publication type:
- Article
Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8‐week, randomized, controlled, double‐blind trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1847, doi. 10.1111/dom.14107
- By:
- Publication type:
- Article
No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1837, doi. 10.1111/dom.14106
- By:
- Publication type:
- Article
Influence of diabetes mellitus on the severity and fatality of SARS‐CoV‐2 (COVID‐19) infection.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1907, doi. 10.1111/dom.14105
- By:
- Publication type:
- Article
Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta‐cell protection in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1827, doi. 10.1111/dom.14104
- By:
- Publication type:
- Article
Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE‐ON study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1818, doi. 10.1111/dom.14103
- By:
- Publication type:
- Article
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1705, doi. 10.1111/dom.14102
- By:
- Publication type:
- Article
Insulin clearance as the major player in the hyperinsulinaemia of black African men without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1808, doi. 10.1111/dom.14101
- By:
- Publication type:
- Article
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1799, doi. 10.1111/dom.14100
- By:
- Publication type:
- Article
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1897, doi. 10.1111/dom.14099
- By:
- Publication type:
- Article
Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26‐week randomized controlled trial; mechanisms of weight loss.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1742, doi. 10.1111/dom.14090
- By:
- Publication type:
- Article
Why is hyperglycaemia worsening COVID‐19 and its prognosis?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1951, doi. 10.1111/dom.14098
- By:
- Publication type:
- Article
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1789, doi. 10.1111/dom.14094
- By:
- Publication type:
- Article
Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1777, doi. 10.1111/dom.14093
- By:
- Publication type:
- Article
Evaluation of the safety of sodium‐glucose co‐transporter‐2 inhibitors for treating patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1767, doi. 10.1111/dom.14092
- By:
- Publication type:
- Article
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1753, doi. 10.1111/dom.14091
- By:
- Publication type:
- Article
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1946, doi. 10.1111/dom.14097
- By:
- Publication type:
- Article
A second‐generation glucagon‐like peptide‐1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1729, doi. 10.1111/dom.14089
- By:
- Publication type:
- Article
Donor insulin use predicts beta‐cell function after islet transplantation.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1874, doi. 10.1111/dom.14088
- By:
- Publication type:
- Article
Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1869, doi. 10.1111/dom.14085
- By:
- Publication type:
- Article
Goal achievement of HbA1c and LDL‐cholesterol in a randomized trial comparing colesevelam with ezetimibe: GOAL‐RCT.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1722, doi. 10.1111/dom.14084
- By:
- Publication type:
- Article
Bolus insulin dose depends on previous‐day race intensity during 5 days of professional road‐cycle racing in athletes with type 1 diabetes: A prospective observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1714, doi. 10.1111/dom.14083
- By:
- Publication type:
- Article
Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 or COVID‐19).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1942, doi. 10.1111/dom.14062
- By:
- Publication type:
- Article
COVID‐19 infection may cause ketosis and ketoacidosis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1935, doi. 10.1111/dom.14057
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1703, doi. 10.1111/dom.13721
- Publication type:
- Article